In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.

And per the American Academy of Dermatology Association, sometimes skin changes like rashes, “netting”, and the appearance of lumps can reveal underlying heart issues, too. The British Journal of ...

A research team has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of ...

RA primarily affects the joints, but it can also cause symptoms in other areas of the body, such as the skin. Learn how RA ...

The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

The US FDA has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid.

This approval marks the eighth disease indication for Dupixent as a new alternative for patients—many of whom are elderly and ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) to treat bullous ...

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) as the first targeted therapy for bullous ...

Sanofi & Regeneron’s Dupixent receives US FDA approval to treat patients with bullous pemphigoid: Paris Saturday, June 21, 2025, 12:00 Hrs [IST] The US Food and Drug Administrat ...

The FDA approved Dupixent for the treatment of adults with bullous pemphigoid, a rare skin disease often uncontrolled with ...

Dupixent approved by FDA for bullous pemphigoid, offering a new option for adults with the rare autoimmune skin disease ...